| # | Drug | Count |
|---|---|---|
| 0 | ADAPALENE | 20273 |
| 1 | AVOBENZONE, OCTISALATE, AND OCTOCRYLENE | 16861 |
| 2 | SALICYLIC ACID | 5774 |
| 3 | DUPILUMAB | 2828 |
| 4 | ADALIMUMAB | 2090 |
| 5 | ETANERCEPT | 1687 |
| 6 | SECUKINUMAB | 1596 |
| 7 | ERGOCALCIFEROL | 1307 |
| 8 | OMEPRAZOLE MAGNESIUM | 1278 |
| 9 | ASPIRIN | 1267 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN | 62 | 0.1325 |
| 1 | AVOBENZONE, OCTISALATE, AND OCTOCRYLENE | 16861 | 0.1304 |
| 2 | ADAPALENE | 20273 | 0.1233 |
| 3 | COAL TAR | 57 | 0.1133 |
| 4 | SALICYLIC ACID | 5774 | 0.1126 |
| 5 | ADAPALENE AND BENZOYL PEROXIDE | 134 | 0.1085 |
| 6 | OCTOCRYLENE, AVOBENZONE | 39 | 0.1080 |
| 7 | CLINDAMYCIN PHOSPHATE AND TRETINOIN | 24 | 0.0984 |
| 8 | BENZOYL PEROXIDE | 535 | 0.0918 |
| 9 | NAFTIFINE HYDROCHLORIDE | 24 | 0.0833 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 21027 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3203 |
| 2 | Corticosteroid [EPC] | 3093 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2828 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 2140 |
| 5 | Kinase Inhibitor [EPC] | 1877 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 1748 |
| 7 | Interleukin-17A Antagonist [EPC] | 1661 |
| 8 | Anti-epileptic Agent [EPC] | 1602 |
| 9 | Benzodiazepine [EPC] | 1541 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Retinoid [EPC] | 21027 | 0.0976 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 17 | 0.0462 |
| 2 | Melanin Synthesis Inhibitor [EPC] | 72 | 0.0450 |
| 3 | Oxaborole Antifungal [EPC] | 28 | 0.0382 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0323 |
| 5 | Vitamin D Analog [EPC] | 114 | 0.0318 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2828 | 0.0290 |
| 7 | Tubulin Inhibiting Agent [EPC] | 6 | 0.0269 |
| 8 | Paramagnetic Contrast Agent [EPC] | 86 | 0.0207 |
| 9 | Chemokine Receptor Type 4 Interaction [EPC] | 13 | 0.0187 |